Drugs / FMP010
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02458092 | Apr → Dec 2008 | malaria | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FMP010 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02458092 ↗ |
| Known as | Plasmodium falciparum Malaria Protein 010 | “Plasmodium falciparum Malaria Protein 010 (FMP010)” NCT02458092 ↗ |
| Modality | Vaccine | “investigational malaria vaccine” NCT02458092 ↗ |
| Route | Intramuscular | “given intramuscularly in the deltoid muscle” NCT02458092 ↗ |